NEW YORK, Jan 11 - Incyte Genomics and Gene Logic have settled a patent infringement lawsuit filed by Incyte against Gene Logic, the companies said Thursday.
The suit, filed in the U. S. District Court for the Northern District of California, alleged infringement of U.S. Patent Numbers 5,716,785, 5,891,636 and 6,023,659.
Under the settlement agreement, the lawsuits will be dismissed and Gene Logic will have a non-exclusive license to practice the technology described in these patents.
Specific settlement and financial terms were not disclosed, in accordance with the terms of the settlement agreement.
U.S. Patents 5,716,785 and 5,891,636, both entitled “Processes for genetic manipulations using promoters,” cover the use of promoters for RNA amplification and other genetic manipulations.
U. S. Patent 6,023,659, “Database system employing protein function hierarchies for viewing biomolecular sequence data,” covers a relational database system that stores biomolecular sequence information so that it may be catalogued and searched according to one or more protein function hierarchies.